Point72 Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,075,673
| Closed | -$20.3M | – | 1681 |
|
|
2024
Q4 | $20.3M | Buy |
+1,075,673
| New | +$20.3M | 0.04% | 390 |
|
|
2023
Q4 | – | Sell |
-1,032
| Closed | -$31.7K | – | 1910 |
|
|
2023
Q3 | $31.7K | Buy |
1,032
+612
| +146% | +$18.8K | ﹤0.01% | 1526 |
|
|
2023
Q2 | $16.8K | Sell |
420
-478,796
| -100% | -$19.2M | ﹤0.01% | 1290 |
|
|
2023
Q1 | $19.6M | Buy |
+479,216
| New | +$19.6M | 0.06% | 327 |
|
|
2020
Q1 | – | Sell |
-30,744
| Closed | -$1.39M | – | 964 |
|
|
2019
Q4 | $1.39M | Sell |
30,744
-300,035
| -91% | -$13.6M | 0.01% | 629 |
|
|
2019
Q3 | $12.6M | Sell |
330,779
-833,862
| -72% | -$31.7M | 0.08% | 288 |
|
|
2019
Q2 | $50.7M | Buy |
1,164,641
+531,059
| +84% | +$23.1M | 0.27% | 85 |
|
|
2019
Q1 | $24.1M | Buy |
633,582
+24,017
| +4% | +$914K | 0.11% | 179 |
|
|
2018
Q4 | $26.2M | Buy |
609,565
+371,169
| +156% | +$16M | 0.13% | 176 |
|
|
2018
Q3 | $11.7M | Buy |
238,396
+136,760
| +135% | +$6.72M | 0.05% | 336 |
|
|
2018
Q2 | $3.26M | Buy |
101,636
+89,936
| +769% | +$2.88M | 0.01% | 553 |
|
|
2018
Q1 | $364K | Sell |
11,700
-489,300
| -98% | -$15.2M | ﹤0.01% | 717 |
|
|
2017
Q4 | $22.9M | Sell |
501,000
-583,886
| -54% | -$26.7M | 0.1% | 229 |
|
|
2017
Q3 | $40.7M | Buy |
1,084,886
+914,686
| +537% | +$34.3M | 0.18% | 126 |
|
|
2017
Q2 | $8.12M | Buy |
170,200
+100,200
| +143% | +$4.78M | 0.05% | 363 |
|
|
2017
Q1 | $3.19M | Buy |
+70,000
| New | +$3.19M | 0.02% | 546 |
|
|
2016
Q3 | – | Sell |
-281,236
| Closed | -$9.49M | – | 760 |
|
|
2016
Q2 | $9.49M | Buy |
+281,236
| New | +$9.49M | 0.06% | 290 |
|